Evidence map›Paper›PMID 41083998›Full record

ArticleGenome biology2025

iPro-MP: a BERT-based model to predict multiple prokaryotic promoters.

Wei Su, Yuhe Yang, Yafei Zhao, Shishi Yuan, Xueqin Xie, Yuduo Hao, Hongqi Zhang, Dongxin Ye, Hao Lyu, Hao Lin

Abstract read
In one paragraph

Article in Genome biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wei SuDepartment of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 610054, People's Republic of China.
Yuhe YangDepartment of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 610054, People's Republic of China.
Yafei ZhaoDepartment of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 610054, People's Republic of China.
Shishi YuanDepartment of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 610054, People's Republic of China.
Xueqin XieDepartment of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 610054, People's Republic of China.
Yuduo HaoDepartment of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 610054, People's Republic of China.
Hongqi ZhangDepartment of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 610054, People's Republic of China.
Dongxin YeDepartment of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 610054, People's Republic of China.
Hao LyuDepartment of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 610054, People's Republic of China. hao.lyu@uestc.edu.cn.
Hao LinDepartment of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 610054, People's Republic of China. hlin@uestc.edu.cn.

Funding

China Postdoctoral Science Foundation 2023TQ0047National Natural Science Foundation of China 62172078National Natural Science Foundation of China 62402089
6 · The paper itself

Abstract

backgroundPromoters, as essential cis-regulatory elements in prokaryotes, govern gene expression by mediating RNA polymerase binding through core motifs and long-range regulatory interactions, playing a pivotal role in cell metabolism and environmental adaptation. Hence, accurate identification of prokaryotic promoters is vital for understanding their biological functions. However, the existing tools for predicting prokaryotic promoters are mainly concentrated on individual model organisms, and their prediction accuracy needs to be further improved. To address these gaps, we develop iPro-MP, a transformer-based prokaryotic promoter prediction framework that we systematically evaluate across 23 phylogenetically diverse species, including both model and non-model organisms.

resultsiPro-MP utilizes a multi-head attention mechanism to capture textual information in DNA sequences and effectively learns the hidden patterns. Cross-species prediction demonstrates the necessity of constructing species-specific models. Through a series of experiments, iPro-MP shows outstanding performance, with the AUC exceeding 0.9 in 18 out of 23 species.

conclusionsOur novel approach to predicting prokaryotic promoters, iPro-MP, provides the superiority to other existing tools, especially in predicting non-model organisms. Finally, for the convenience of other researchers, the source code and datasets of iPro-MP are freely available at https://github.com/Jackie-Suv/iPro-MP .

Indexed as

Prokaryotic CellsPromoter Regions, GeneticSoftwareBacteriaDeep learningLarge language modelProkaryotic promoters

Identifiers

PMID41083998
PMCPMC12516880

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.